Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 3

Status

Unknown 2Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Sarcoma 3Gastrointestinal 3Breast 3Head & Neck 2Gynecologic 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Sarcoma 3Lung Neoplasms 3Head and Neck Neoplasms 3Breast Neoplasms 3Brain Neoplasms 3Stomach Neoplasms 2Pancreatic Neoplasms 2Neuroectodermal Tumors 2Nervous System Diseases 2Neoplasms, Neuroepithelial 2Neoplasms, Nerve Tissue 2Neoplasms 2Liver Neoplasms 2Gliosarcoma 2Glioma 2Glioblastoma 2Colorectal Neoplasms 2Carcinoma 2Virus Diseases 1Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Pharyngeal Neoplasms 1Ovarian Neoplasms 1Otorhinolaryngologic Neoplasms 1Nose Neoplasms 1Neoplasms, Glandular and Epithelial 1Neoplasms, Germ Cell and Embryonal 1Neoplasms by Histologic Type 1Melanoma 1Laryngeal Neoplasms 1

Interventions

Trastuzumab 209Paclitaxel 187Fulvestrant 161Capecitabine 150Docetaxel 136Letrozole 127exemestane 92palbociclib 76Anastrozole 75Cyclophosphamide 71Lapatinib 69Gemcitabine 66Bevacizumab 66pertuzumab 61ribociclib 60pembrolizumab 60Carboplatin 59abemaciclib 53eribulin 48Doxorubicin 45Vinorelbine 41Everolimus 41Ado-Trastuzumab Emtansine 41Tamoxifen 40130-nm albumin-bound paclitaxel 34Injections 31trastuzumab deruxtecan 30Albumin-Bound Paclitaxel 26olaparib 24Alpelisib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Breast Neoplasms × Oncolytic Virotherapy × Clear all
NCT05961111 2023-07-27

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

Shanghai Yunying Medical Technology

Phase EARLY_PHASE1 Recruiting
20 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Sarcoma

NCT05886075 2023-06-02

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

Shanghai Yunying Medical Technology

Phase EARLY_PHASE1 Unknown
24 enrolled
BreastGastrointestinalGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT05860374 2023-05-16

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors

Shanghai Yunying Medical Technology

Phase EARLY_PHASE1 Unknown
20 enrolled
BreastGastrointestinalSarcomaThoracic

Breast Neoplasms, Carcinoma, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡